Diabetes

DR Care: It Takes a Village

Allen C. Ho, MD; Robert L. Avery, MD; and Lejla Vajzovic, MD, FASRS

Can OCTA Help Predict DR Progression?

Quantitative biomarkers may add a new dimension to the assessment and risk stratification of diabetic retinopathy.

Kallista Zhuang, BA; Shinji Kakihara, MD, PhD; and Amani A. Fawzi, MD

Pearls for Managing Complex Diabetic Vitrectomy

Diabetic tractional retinal detachments are challenging for even the most seasoned surgeons. Following these steps can help minimize complications.

Neil Sheth, MD, MBA, and Dimitra Skondra, MD, PhD

Global DR Screening: Why Aren’t We There Yet?

A look at the hope and hurdles of global screening implementation.

Majda Hadziahmetovic, MD; Michael D. Abramoff, MD, PhD; Abdullah AlQahtani, MD, DES, DISSO, FEBO; Gavin Tan Siew Wei, MBBS, PhD; Sobha Sivaprasad, MBBS, MS, DM, FRCS, FRCOphth; Lloyd Harrison-Williams, MD; and Jorge C. P. Rocha, MD, PhD

AI in DME: From Promise to Clinical Practice

New data show the growing utility of AI-assisted screening, referrals, and treatment response prediction.

Scott Song, BA, and T. Y. Alvin Liu, MD

The Potential of Tyrosine Kinase Inhibitors

This novel class of drug may one day help to address the growing burden of diabetic eye disease.

Shawn Kavoussi, MD

A Look at Implants for Diabetic Eye Disease

A review of approved and emerging implant-based treatments for diabetic retinopathy and diabetic macular edema.

Matthew Pfannenstiel, MD, and Leanne M. Clevenger, MD

Anti-VEGF Step Therapy: An Update

Despite ongoing advocacy efforts, this payer policy persists, putting vision at risk.

Lucas McGuire, BS; Baseer Ahmad, MD; and Jennifer Adeghate, MD, PhD

Teleretinal Screening: Closing the Gap in Diabetic Eye Care

Meeting patients where they are—community health centers—can improve screening rates and save vision.

Alice C. Lorch, MD, MPH

Advances in Therapy for Diabetic Eye Disease

The pipeline is rich with therapies that promise reduced treatment burden and improved efficacy.

Alicia H. Chen, MD; Jacob Holland, BS; and Sally S. Ong, MD

DR Stability With Automated Insulin Delivery

Our study indicates the benefits of improved glycemic control outweigh the small potential risk of worsening diabetic eye disease.

Francesc March de Ribot, MD, PhD, and Ben Wheeler, MD, PhD

PDR in the Setting of Oculocutaneous Albinism

Panretinal photocoagulation was sufficient to treat this patient’s vitreous hemorrhage and extensive neovascularization.

James Dossett, MD; Christine Clavell, MD; and Ghassan Ghorayeb, MD, MBA

Managing DR in Patients with Good Vision

The DRCR Retina Network sheds light on the optimal treatment approaches.

Gage Hazelton, BA, and Deepak Sambhara, MD

Utility of Fluorescein Angiography in DME

If you want to assess vessel leakage and peripheral pathology in diabetic eye disease, FA is still your best bet.

Jason Keil, MD, PhD; Caitlyn Cooper, MA; and Yannis M. Paulus, MD

The Emerging Role of AI in DR Screening

AI-powered technologies could help ophthalmologists meet the growing needs of this patient population.

Jorge C. P. Rocha, MD, PhD, and Majda Hadziahmetovic, MD

GLP-1 Receptor Agonists and the Eye

Researchers are working to understand the effects of these popular new therapies on ocular structures.

Suraj Bala, BS; Julia H. Joo, MD; and Aleksandra V. Rachitskaya, MD, FASRS

A Call for Holistic Care

Allen C. Ho, MD, and Robert L. Avery, MD

Minding the Gap: Diabetes Day Reduces Barriers to Care

Growing statewide effort increases access to diabetic eye care and reduces preventable blindness through free screening services.

Christian D. Raimondo, MS; Leah Prischak, BS; Charlotte N. Shields, MD; Rachel E. Cain; Elizabeth Goldstein, BS; Madison Woods, BS; Ari H. August, BA; Arslon Humayun, BA; and Allen C. Ho, MD

Modern Diabetes Care: What You Need to Know

The changing landscape of systemic diabetes care is affecting ocular complications such as diabetic retinopathy.

Samaantar Joshi, BS; Khiem Sy Nguyen, BS; Jonathan B. Lin, MD, PhD; and Ehsan Rahimy, MD

Teaching Fibrovascular Membrane Dissection

Use this structured approach to teach fellows how to manage complex diabetic eye disease in the OR.

James Rice, FCOphth(SA), MPH; Thabang Morris, FCOphth(SA); and Jonel Steffen, FCOphth(SA)